Lista de obras - Gamal E. Shiha - Dominio Público Uruguay

A discriminant score based on four routine laboratory blood tests for accurate diagnosis of severe fibrosis and/or liver cirrhosis in Egyptian patients with chronic hepatitis C.

artículo científico publicado en 2006

A novel antigen detection immunoassay for field diagnosis of hepatitis C virus infection.

artículo científico publicado en 2003

A same day 'test and treat' model for chronic HCV and HBV infection: Results from two community-based pilot studies in Egypt

scientific article published on 30 January 2020

A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis C.

artículo científico publicado en 2017

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014.

artículo científico publicado en 2014

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update

scientific article published on 06 June 2019

An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project

artículo científico publicado en 2018

Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis

artículo científico publicado en 2020

Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update

artículo científico publicado en 2016

Change in the hepatic profile of hepatitis C virus genotype 4-infected patients with compensated cirrhosis receiving ombitasvir, paritaprevir, and ritonavir plus ribavirin: A subanalysis of the AGATE-II study

Chronic Hepatitis C Patients with Obesity: Do we Need two Operators for Accurate Evaluation of Liver Stiffness?

artículo científico publicado en 2018

Comparison of early treatment with low doses of nilotinib, imatinib and a clinically relevant dose of silymarin in thioacetamide-induced liver fibrosis

artículo científico publicado en 2011

Comparison of imatinib, nilotinib and silymarin in the treatment of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis.

artículo científico publicado en 2011

Consensus on extra-hepatic portal vein obstruction

artículo científico publicado en 2006

Current status and future directions in the management of chronic hepatitis C.

artículo científico publicado en 2012

Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: analysis of a global dataset

artículo científico publicado en 2019

Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure.

artículo científico publicado en 2017

Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations

artículo científico publicado en 2011

Diagnostic performance of T lymphocyte subpopulations in assessment of liver fibrosis stages in hepatitis C virus patients: simple noninvasive score.

artículo científico publicado en 2016

Discriminant function based on hyaluronic acid and its degrading enzymes and degradation products for differentiating cirrhotic from non-cirrhotic liver diseased patients in chronic HCV infection

artículo científico publicado en 2006

Effect of human umbilical cord blood derived CD34+ hematopoietic stem cell on the expression of Wnt4 and P53 genes in a rat model of hepatocellular carcinoma.

artículo científico publicado en 2018

Evaluation of serum procollagen aminoterminal propeptide III, laminin, and hydroxyproline as predictors of severe fibrosis in patients with chronic hepatitis C

artículo científico publicado en 2007

Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection

artículo científico publicado en 2008

GES: A validated simple score to predict risk of HCC in patients with HCV-GT4 associated advanced liver fibrosis after oral antivirals

artículo científico publicado en 2020

Gastric variceal ligation: a new technique

artículo científico publicado en 1999

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

artículo científico publicado en 2018

HCC-DETECT: a combination of nuclear, cytoplasmic, and oncofetal proteins as biomarkers for hepatocellular carcinoma

artículo científico publicado en 2015

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

artículo científico publicado en 2014

Identification of a specific marker for hepatitis C virus infection using capillary zone electrophoresis

artículo científico publicado en 2004

Immunochemical identification and detection of serum fibronectin in liver fibrosis patients with chronic hepatitis C.

artículo científico publicado en 2007

Immunochemical identification and partial characterization of a native hepatitis C viral non-structural 4 antigen in sera of HCV infected patients

artículo científico publicado en 2007

Immunohistochemical identification of HCV target antigen in paraffin-embedded liver tissue: reproducibility and staining patterns

artículo científico publicado en 2005

Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective study

artículo científico publicado en 2020

Interferon-gamma is associated with hepatic dysfunction in fibrosis, cirrhosis, and hepatocellular carcinoma.

artículo científico publicado en 2016

Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt.

artículo científico publicado en 2018

Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models.

artículo científico publicado en 2017

Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL).

artículo científico publicado en 2008

Nilotinib counteracts thioacetamide-induced hepatic oxidative stress and attenuates liver fibrosis progression

artículo científico publicado en 2011

Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases

artículo científico publicado en 2013

Non-invasive assessment of portal hypertension and liver fibrosis using contrast-enhanced ultrasonography

artículo científico publicado en 2015

Noninvasive estimation of liver fibrosis in biopsy-proven hepatitis C virus-infected patients: angiogenic fibrogenic link.

artículo científico publicado en 2016

Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial.

artículo científico publicado en 2016

PD-L1 Expression on Circulating CD34＋ Hematopoietic Stem Cells Closely Correlated with T-cell Apoptosis in Chronic Hepatitis C Infected Patients

artículo científico publicado en 2017

Phylogenetic analysis of B2L gene of Egyptian orf virus from naturally infected sheep

artículo científico publicado en 2015

Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver

artículo científico publicado en 2008

Regression of fibrosis in paediatric autoimmune hepatitis: morphometric assessment of fibrosis versus semiquantiatative methods

artículo científico publicado en 2009

Reply to: Suboptimal accuracy of GES score to stratify post SVR HCC risk in a single-center cohort of European cirrhotics

artículo científico publicado en 2020

Role of hyaluronic acid, its degrading enzymes, degradation products, and ferritin in the assessment of fibrosis stage in Egyptian patients with chronic hepatitis C ⬇️

artículo científico publicado el 1 de enero de 2013

Sofosbuvir plus Daclatasvir with or without ribavirin for treatment of chronic HCV genotype 4 patients: real-life experience

artículo científico publicado en 2018

Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4.

artículo científico publicado en 2015

Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt.

artículo científico publicado en 2017

Strategies to manage hepatitis C virus (HCV) disease burden.

artículo científico publicado en 2014

Systemic Inflammatory Response Syndrome in Acute on Chronic Liver Failure- Relevance of 'Golden Window'- a Prospective Study

artículo científico publicado en 2017

The Potential Safe Antifibrotic Effect of Stem Cell Conditioned Medium and Nilotinib Combined Therapy by Selective Elimination of Rat Activated HSCs

artículo científico publicado en 2021

The current and future disease burden of chronic hepatitis C virus infection in Egypt

artículo científico

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

artículo científico publicado en 2014

The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trial.

artículo científico publicado en 2016

The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference.

artículo científico publicado en 2013

Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: an insight

artículo científico publicado en 2014

Treatment of Chronic Hepatitis C Infection Among Egyptian Kidney Transplant Recipients: A Pilot Study

scientific article published on 01 January 2019

Treatment of hepatitis C infection among Egyptian hemodialysis patients: the dream becomes a reality

scientific article published on 30 July 2019

Lista de obras de Gamal E. Shiha

A discriminant score based on four routine laboratory blood tests for accurate diagnosis of severe fibrosis and/or liver cirrhosis in Egyptian patients with chronic hepatitis C.

A novel antigen detection immunoassay for field diagnosis of hepatitis C virus infection.

A same day 'test and treat' model for chronic HCV and HBV infection: Results from two community-based pilot studies in Egypt

A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis C.

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014.

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update

An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project

Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis

Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update

Change in the hepatic profile of hepatitis C virus genotype 4-infected patients with compensated cirrhosis receiving ombitasvir, paritaprevir, and ritonavir plus ribavirin: A subanalysis of the AGATE-II study

Chronic Hepatitis C Patients with Obesity: Do we Need two Operators for Accurate Evaluation of Liver Stiffness?

Comparison of early treatment with low doses of nilotinib, imatinib and a clinically relevant dose of silymarin in thioacetamide-induced liver fibrosis

Comparison of imatinib, nilotinib and silymarin in the treatment of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis.

Consensus on extra-hepatic portal vein obstruction

Current status and future directions in the management of chronic hepatitis C.

Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: analysis of a global dataset

Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure.

Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations

Diagnostic performance of T lymphocyte subpopulations in assessment of liver fibrosis stages in hepatitis C virus patients: simple noninvasive score.

Discriminant function based on hyaluronic acid and its degrading enzymes and degradation products for differentiating cirrhotic from non-cirrhotic liver diseased patients in chronic HCV infection

Effect of human umbilical cord blood derived CD34+ hematopoietic stem cell on the expression of Wnt4 and P53 genes in a rat model of hepatocellular carcinoma.

Evaluation of serum procollagen aminoterminal propeptide III, laminin, and hydroxyproline as predictors of severe fibrosis in patients with chronic hepatitis C

Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection

GES: A validated simple score to predict risk of HCC in patients with HCV-GT4 associated advanced liver fibrosis after oral antivirals

Gastric variceal ligation: a new technique

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

HCC-DETECT: a combination of nuclear, cytoplasmic, and oncofetal proteins as biomarkers for hepatocellular carcinoma

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

Identification of a specific marker for hepatitis C virus infection using capillary zone electrophoresis

Immunochemical identification and detection of serum fibronectin in liver fibrosis patients with chronic hepatitis C.

Immunochemical identification and partial characterization of a native hepatitis C viral non-structural 4 antigen in sera of HCV infected patients

Immunohistochemical identification of HCV target antigen in paraffin-embedded liver tissue: reproducibility and staining patterns

Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective study

Interferon-gamma is associated with hepatic dysfunction in fibrosis, cirrhosis, and hepatocellular carcinoma.

Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt.

Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models.

Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL).

Nilotinib counteracts thioacetamide-induced hepatic oxidative stress and attenuates liver fibrosis progression

Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases

Non-invasive assessment of portal hypertension and liver fibrosis using contrast-enhanced ultrasonography

Noninvasive estimation of liver fibrosis in biopsy-proven hepatitis C virus-infected patients: angiogenic fibrogenic link.

Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial.

PD-L1 Expression on Circulating CD34＋ Hematopoietic Stem Cells Closely Correlated with T-cell Apoptosis in Chronic Hepatitis C Infected Patients

Phylogenetic analysis of B2L gene of Egyptian orf virus from naturally infected sheep

Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver

Regression of fibrosis in paediatric autoimmune hepatitis: morphometric assessment of fibrosis versus semiquantiatative methods

Reply to: Suboptimal accuracy of GES score to stratify post SVR HCC risk in a single-center cohort of European cirrhotics

Role of hyaluronic acid, its degrading enzymes, degradation products, and ferritin in the assessment of fibrosis stage in Egyptian patients with chronic hepatitis C ⬇️

Sofosbuvir plus Daclatasvir with or without ribavirin for treatment of chronic HCV genotype 4 patients: real-life experience

Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4.

Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt.

Strategies to manage hepatitis C virus (HCV) disease burden.

Systemic Inflammatory Response Syndrome in Acute on Chronic Liver Failure- Relevance of 'Golden Window'- a Prospective Study

The Potential Safe Antifibrotic Effect of Stem Cell Conditioned Medium and Nilotinib Combined Therapy by Selective Elimination of Rat Activated HSCs

The current and future disease burden of chronic hepatitis C virus infection in Egypt

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trial.

The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference.

Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: an insight

Treatment of Chronic Hepatitis C Infection Among Egyptian Kidney Transplant Recipients: A Pilot Study

Treatment of hepatitis C infection among Egyptian hemodialysis patients: the dream becomes a reality